Centiva Capital, LP Frazier Lifesciences Acquisition Corp Transaction History

Centiva Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.83 - $9.9 $130,483 - $131,412	13,274 Added 125.46%	23,854 $236,000
Q1 2022 May 16, 2022	BUY	$9.75 - $9.85 $103,155 - $104,213	10,580 New	10,580 $104,000
Q3 2021 Nov 15, 2021	SELL	$9.66 - $10.0 $278,227 - $288,020	-28,802 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.7 - $10.14 $36,879 - $38,552	3,802 Added 15.21%	28,802 $281,000
Q1 2021 May 17, 2021	BUY	$9.67 - $10.71 $241,750 - $267,750	25,000 New	25,000 $249,000

Ticker FLAC
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 14,301,000
Description
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.